De la Serna, E. http://orcid.org/0000-0002-7869-9881
Puig, O.
Mezquida, G.
Moreno-Izco, L.
Merchan-Naranjo, J.
Amoretti, S.
Ruiz, P.
Gonzalez-Pinto, A.
Molina-García, M.
Corripio, I.
Vieta, E.
Baeza, I.
Berge, D.
Penadés, R.
Sanchez-Torres, A.
Cuesta, M. J.
Bernardo, M.
Castro-Fornieles, J.
Madero, Santiago
Anmella, Gerard
Abregu, Renzo
Rapado-Castro, Marta
Alonso-Solís, Anna
Grasa, Eva
Zorrilla, Iñaki
Gonzalez-Ortega, Itxaso
Saz, Pedro
De-la-Camara, Concepción
Escarti, Jose
Etxeandia-Pradera, Jon-Iñaki
Martínez, Laura
Legido, Teresa
Sagué-Vilavella, Maria
Montejo, Laura
Sugranyes, Gisela
Camprodon-Boadas, Patricia
Contreras, Fernando
Saiz-Masvidal, Cristina
Seijo, Elisa
Bobes, Teresa
Gutierrez, Miguel
Zabala, Arantzazu
Rodríguez-Jiménez, Roberto
Usall, Jusdith
Butllosa, Anna
Sanchez-Pastor, Luis
Sarro, Salvador
Pomarol, Edith
Ibañez, Angela
Lorente-Omeña, Ruth
Balanza, Vicente
,
Funding for this research was provided by:
Instituto de Salud Carlos III (PI08/0208, PI11/00325, PI14/00612)
Secretaria d'Universitats i Recerca of the Government of Catalonia (2017SGR1355, 2017SGR1365; 2017SGR881)
Centro de Investigación Biomédica en Red de Salud Mental
Article History
Received: 15 February 2021
Accepted: 24 October 2021
First Online: 29 October 2021
Declarations
:
: AG-P has received grants and served as consultant, advisor or CME speaker for the following entities: Janssen-Cilag, Lundbeck, Otsuka, Pfizer, Sanofi-Aventis, Alter, Angelini, Exeltis, Takeda, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. MM-G was supported by a Tatiana Pérez de Guzmán el Bueno predoctoral Fellowship. EV has received grants and served as consultant, advisor or CME speaker unrelated to the present work for the following entities: AB-Biotics, Abbott, Allergan, Angelini, Dainippon Sumitomo Pharma, Ferrer, GH Research, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sage, Sanofi-Aventis, Sunovion, and Takeda. IB has received honoraria or travel support from Otsuka-Lundbeck, Angelini and Janssen, research support from Fundación Alicia Koplowitz and grants from Spanish Ministry of Health, Instituto de Salud Carlos III. MB has been a consultant for, received grant/research support and honoraria from, and been on the speakers/advisory board of ABBiotics, Adamed, Angelini, Casen Recordati, Janssen-Cilag, Menarini, Lundbeck, Otsuka, Rovi and Takeda. ES and the remaining members of the PEPs group have no personal affiliations or financial relationships with any commercial interests to disclose relative to the article.